Remote-controlled Capsule Endoscopy: a Feasibility Study
NCT ID: NCT01946633
Last Updated: 2013-10-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The product was developed and manufacture in China.(the NaviCam. AKC-1.China)
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Esophagogastroduodenoscopy（ECG）
n=15
magnetic-controlled capsule endoscopy(Navicam)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
magnetic-controlled capsule endoscopy(Navicam)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* surveillance gastroscopy for known gastric ulcer or polyps
* history of gastric ulcer or polyps （≤1w）at Nanfang Hospital were enrolled.
Exclusion Criteria
* suspected or documented digestive tract malformation ,obstruction, strictures or fistula
* acute upper GI bleeding, acute enteritis, acute ischemia disease
* history of abdominal operations
* impaired renal function, congestive heart failure
* patients with critical condition or mental illness
* patients with, known allergy to polymer material or antifoam agent
* patients with cardiac pacemakers or other implanted electromedical devices，magnetic resonance imaging ( mri) examination in 7 days
* pregnancy
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nanfang Hospital, Southern Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
xinying wang
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Departement of Gastroenterology, Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Xinying Wang, Associate Professor
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Keller J, Fibbe C, Volke F, Gerber J, Mosse AC, Reimann-Zawadzki M, Rabinovitz E, Layer P, Schmitt D, Andresen V, Rosien U, Swain P. Inspection of the human stomach using remote-controlled capsule endoscopy: a feasibility study in healthy volunteers (with videos). Gastrointest Endosc. 2011 Jan;73(1):22-8. doi: 10.1016/j.gie.2010.08.053. Epub 2010 Nov 9.
Related Links
Access external resources that provide additional context or updates about the study.
Inspection of the human stomach using remote-controlled capsule endoscopy: a feasibility study in healthy volunteers
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GNF-NaviCam-001
Identifier Type: -
Identifier Source: org_study_id